Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia
This study has been completed.
Study NCT01034085   Information provided by National Institutes of Health Clinical Center (CC)

First Received on December 16, 2009.   Last Updated on December 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nicotine Dependence
Schizophrenia
Additional conditions recognized in this trial
Tobacco Use Disorder
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Substance-Related Disorders
Additional drug interventions recognized in this trial
Nicotine
More general drug interventions related to this trial
Autonomic Agents
Cholinergic Agents
Cholinergic Agonists
Ganglionic Stimulants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services